Calls for papers
-
Automation company RTS Life Science has formed a new team comprised of US and UK engineering and sales personnel. The move comes after the recent acquisition of a Massacheusetts company and the opening of a… Read more . . .
-
Jamie Clayton has been appointed Operations Manager for Freeman Technology, responsible for all day-to-day operations, including R&D, production, and sales. According to Freeman, it added the position in anticipation of further growth for the company,… Read more . . .
-
A study by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) shows that a combination of tiotropium bromide with a low dose of inhaled corticosteroid (ICS) provides better… Read more . . .
-
Novartis has announced that its Phase III INSIST study shows that its once-daily Onbrez Breezhaler indacaterol DPI produces better bronchodilation in COPD patients than does twice-daily salmeterol. Onbrez also reduced the need for rescue medication,… Read more . . .
-
Boston Scientific has acquired Asthmatx, the developer of a bronchial thermoplasty procedure marketed as an alternative to inhaled medications for the treatment of severe asthma for an upfront payment of $193.5 million and future payments… Read more . . .
-
Version 3.10 of Copley Scientific’s CITDAS inhaler testing software is now available, according to the company. The new version, available as a free upgrade for current CITDAS v3.00 users, includes automatic data importation from Waters… Read more . . .
-
Japan has approved Daiichi Sankyo’s Inavir laninamivir dry powder inhaler for the treatment of influenza. Treatment with Inavir requires only a single inhaled 40 mg dose. Read the Daiichi Sankyo Read more . . .
-
A survey sponsored by the University of Michigan’s C. S. Mott Children’s Hospital found support for regulation of e-cigarettes, with 82% of the US adults polled agreeing that the FDA should regulate the products. Approximately… Read more . . .
-
A PD study has shown no statistically significant difference in pulmonary artery pressure effects of Levadex inhaled dihydroergotamine (DHE) compared to placebo, according to MAP Pharmaceutical. The inhaled formulation had a smaller effect on pulmonary… Read more . . .
-
Prosonix has announced the availability of a new co-crystal development and processing service using its ultrasound technology for the manufacture of co-crystal APIs for inhalation products. According to the company, the process creates co-crystals with… Read more . . .
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 21-October 22: MVIC Symposium, Lund, Sweden
October 28-October 30: Deutches Aerosol Therapie Symposium (DATS), Marburg, Germany
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland